Web21 hours ago · What happened. Shares of CRISPR Therapeutics ( CRSP 16.66%) were up 15% Thursday morning, a day after a drug-pricing group said the company's single-dose … WebMar 31, 2024 · Crispr Therapeutics AG’s trailing 12-month revenue is $1.2 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts …
Money & Markets: The latest technology to invest in – gene …
WebMar 31, 2024 · Crispr Therapeutics AG’s trailing 12-month revenue is $1.2 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-6.687 per share for the current fiscal year. Crispr Therapeutics AG does not currently pay a dividend. The Biotechnology and Medical Research sub ... WebOct 9, 2024 · CRISPR Therapeutics closed Thursday at $95.39. The stock is up 57 percent this year but is still trading 10 percent below its 52-week high. Meanwhile, Beam Therapeutics stock closed Thursday at ... ostacolo riviera
Should You Invest in CRISPR? - Medium
WebApr 8, 2024 · CRISPR's first approved product may be right around the corner. CRISPR Therapeutics ( CRSP -0.68%) works in the cutting-edge space of gene editing. The … WebNov 18, 2024 · To gain an understanding of the value of Exa-Cel as a therapy, Vertex paid Crispr Therapeutics ~$1bn in 2024 to increase its share of global net sales from 50%, to 60%, implying Vertex values Exa ... WebMar 6, 2024 · 3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing CRISPR/Cas is a new technology with the potential to cure genetic diseases, making … osta flipperi